Get the app
US › Healthcare

Mangoceuticals, Inc. Common Stock (MGRX)

US · Healthcare · Health Information Services

$0.29-9.66%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$68,757
Revenue YoY
-59.1%
Net profit
$-1.3M
EPS
$-0.09
Net margin
-1,909.1%

Key statistics

Market cap
$8.3M
Forward P/E
0.0
P/B
0.78
Book value
$0.69
EPS (TTM)
$-1.02
52-week high
$2.75
52-week low
$0.16
50-day MA
$0.44
200-day MA
$0.44
Beta
1.98

Shareholding

Insiders
17.61%
Institutions
5.46%

Largest institutional holders

FundStake
Citadel Advisors Llc1.57%
XTX Topco Ltd0.86%
Geode Capital Management, LLC0.72%
Ikarian Capital, LLC0.64%
Vanguard Capital Management, LLC0.57%
Vanguard Fiduciary Trust Co0.27%
BOOTHBAY FUND MANAGEMENT, LLC0.18%
Northern Trust Corp0.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Mangoceuticals, Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.